It's beating expectations, beating guidance, generating robust operating and free cash flows, and steadily rising recurring revenues.
Let's see how this small health care name could give big returns by the end of 2023.
This cutting-edge technology company is poised to propel artificial intelligence to the next level.
Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.
The shares of the biopharmaceutical company appear to have broken out to the upside.
The charts of the farm equipment giant suggest its stock could head downward significantly in the weeks ahead.
The FOMC will have to altar market expectations for the November 1st decision in order to restore flexibility/optionality in decision making.
The battle continues, and the best way to navigate it is to stay focused on price action.
Let's pop the hood and check the market's mood -- and that low VIX reading.
Let's digest the economic news of the day, why we rallied, and what perils could be ahead.